Azenta, Inc.AZTANASDAQ

52-Week Range20-42

19.94Current 20.1941.73

Want to monitor AZTA?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

azenta (nasdaq: azta) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster.

Professional, Scientific, and Technical Services

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Stephen Schwartz

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Amazon Gets Its Biggest Hit Movie Ever With ‘Project Hail Mary'

The Best 3 Renewable Energy Stocks to Buy and Hold for Decades

Paramount And Warner Bros. Discovery Combined Will Control 40% Of Acquired TV Viewing On Streaming.

Here's Why High Oil Prices Are Hurting Precious Metals Mining Stocks

IonQ's Revenue Just Tripled to $130 Million. Is This Quantum Stock Finally Worth Buying?

This Investor Exited a $22 Million GRAIL Stake Before a 50% One-Day Stock Crash Last Month

Is Lemonade a Buy After Morgan Stanley's Upgrade?

24 Safer Buys From 10 Years Of Dogcatcher Digging

ROSEN, A LONGSTANDING LAW FIRM, Encourages Concorde International Group Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIGL

METC IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Ramaco Resources, Inc. Investors to Secure Counsel Before Important March 31 Deadline in Securities Class Action - METC

Elon Musk unveils chip manufacturing plans for SpaceX and Tesla

Why a Full Exit From Cogent Communications Amid a 74% Stock Drop Could Matter for Investors

The Era of AI Agents Has Arrived. 2 Stocks on Track to Win.

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?

Tesla, SpaceX Plan to Build New Chip Factory in Texas

Why This Standout Vanguard Dividend ETF Is Better Poised for Growth Than You Think

Rosen Law Firm Encourages Vital Farms, Inc. Investors to Inquire About Securities Class Action Investigation - VITL

Is Palo Alto Networks Stock a Buy Now?

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Gartner, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IT

Why a $3.5 Million Bet Targets Avantor Amid a 54% Stock Drop

About